Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness

Frontiers in Psychiatry

Volumn 3, Issue NOV, 2012, Pages

  Mamah, Daniel ^a   Harms, Michael P ^a   Barch, Deanna ^a   Styner, Martin ^b   Lieberman, Jeffrey A ^c   Wang, Lei ^d  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Haloperidol; Hippocampus; MRI; Olanzapine; Psychosis; Schizophrenia

Indexed keywords

HALOPERIDOL; OLANZAPINE;

ADULT; ANATOMICAL VARIATION; ARTICLE; BRAIN FUNCTION; BRAIN MAPPING; BRAIN REGION; BRAIN SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; VOLUMETRY;

EID: 84870913886     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2012.00096     Document Type: Article

References (83)

1. Abdul-Monim, Z., Reynolds, G. P., and Neill, J. C. (2003). The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. J. Psychopharmacol. (Oxford) 17, 57-65.
2. Ashburner, J., Csernansky, J. G., Davatzikos, C., Fox, N. C., Frisoni, G. B., and Thompson, P. M. (2003). Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol. 2, 79-88.
3. Bai, O., Chlan-Fourney, J., Bowen, R., Keegan, D., and Li, X. M. (2003). Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J. Neurosci. Res. 71, 127-131.
4. Boyer, P., Phillips, J. L., Rousseau, F. L., and Ilivitsky, S. (2007). Hip-pocampal abnormalities and memory deficits: new evidence of a strong pathophysiological link in schizophrenia. Brain Res. Rev. 54, 92-112.
5. Carlsson, A. (1978). Antipsychotic drugs, neurotransmitters, and schizophrenia. Am. J. Psychiatry 135, 165-173.
6. Chakos, M. H., Lieberman, J. A., Bilder, R. M., Borenstein, M., Lerner, G., Bogerts, B., et al. (1994). Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am. J. Psychiatry 151, 1430-1436.
7. Chakos, M. H., Shirakawa, O., Lieberman, J., Lee, H., Bilder, R., and Tamminga, C. A. (1998). Striatal enlargement in rats chronically treated with neuroleptic. Biol. Psychiatry 44, 675-684.
8. Cohen, R. M., Nordahl, T. E., Semple, W. E., and Pickar, D. (1999). The brain metabolic patterns of clozapine- and fluphenazine-treated female patients with schizophrenia: evidence of a sex effect. Neuropsychopharmacology 21, 632-640.
9. Corlett, P. R., Krystal, J. H., Taylor, J. R., and Fletcher, P. C. (2009). Why do delusions persist? Front. Hum. Neurosci. 3:12. doi:10.3389/neuro.09.012.2009
10. Csernansky, J. G., Joshi, S., Wang, L., Haller, J. W., Gado, M., Miller, J. P., et al. (1998). Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc. Natl. Acad. Sci. U.S.A. 95, 11406-11411.
11. Csernansky, J. G., Wang, L., Jones, D., Rastogi-Cruz, D., Posener, J. A., Heydebrand, G., et al. (2002). Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. Am. J. Psychiatry 159, 2000-2006.
12. Csernansky, J. G., Wang, L., Joshi, S. C., Ratnanather, J. T., and Miller, M. I. (2004). Computational anatomy and neuropsychiatric disease: probabilistic assessment of variation and statistical inference of group difference, hemispheric asymmetry, and time-dependent change. Neuroimage 23(Suppl. 1), S56-S68.
13. Csernansky, J. G., Wang, L., Swank, J., Miller, J. P., Gado, M., McKeel, D., et al. (2005). Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage 25, 783-792.
14. Davis, K. (1999). The course of schizophrenia: evidence for dynamic change processes. Biol. Psychiatry 45(Suppl.), 985.
15. Dazzan, P., and Murray, R. M. (1999). Schizophrenia is (not simply) a neurodevelopmental disorder. Epidemiol. Psichiatr. Soc. 8, 235-241.
16. Degreef, G., Ashtari, M., Wu, H. W., Borenstein, M., Geisler, S., and Lieberman, J. (1991). Follow up MRI study in first episode schizophrenia. Schizophr. Res. 5, 204-206.
17. DeLisi, L.E., Sakuma, M., Tew, W., Kushner, M., Hoff, A. L., and Grimson, R. (1997). Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 74, 129-140.
18. Dorph-Petersen, K. A., Pierri, J. N., Perel, J. M., Sun, Z., Sampson, A. R., and Lewis, D. A. (2005). The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30, 1649-1661.
19. Duncan, G. E., Miyamoto, S., Leipzig, J. N., and Lieberman, J. A. (2000). Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. J. Pharmacol. Exp. Ther. 293, 8-14.
20. Ebdrup, B. H., Glenthoj, B., Rasmussen, H., Aggernaes, B., Langk-ilde, A. R., Paulson, O. B., et al. (2010). Hippocampal and caudate volume reductions in antipsychoticnaive first-episode schizophrenia. J. Psychiatry Neurosci. 35, 95-104.
21. First, M. B., Spitzer, R. L., Gibbon, M., and Williams, J. B. W. (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). NewYork: Biometrics Research,New York Psychiatric Institute.
22. Freeborough, P. A., Woods, R. P., and Fox, N. C. (1996). Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders. J. Comput. Assist. Tomogr. 20, 1012-1022.
23. Fumagalli, F., Molteni, R., Roceri, M., Bedogni, F., Santero, R., Fossati, C., et al. (2003). Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-d-aspartate receptor activity. J. Neurosci. Res. 72, 622-628.
24. Goldberg, T. E., Aloia, M. S., Gourovitch, M. L., Missar, D., Pickar, D., and Weinberger, D. R. (1998). Cognitive substrates of thought disorder, I: the semantic system. Am. J. Psychiatry 155, 1671-1676.
25. Gouttard, S., Styner, M., Joshi, S., Smith, R. G., Hazlett, H. C., and Gerig, G. (2007). Subcortical structure segmentation using probabilistic atlas priors. Proc. SPIE 6512, 65122J1- 65122J11.
26. Gur, R. C., Mozley, P. D., Resnick, S. M., Gottlieb, G. L., Kohn, M., Zimmerman, R., et al. (1991). Gender differences in age effect on brain atrophy measured by magnetic resonance imaging. Proc. Natl. Acad. Sci. U.S.A. 88, 2845-2849.
27. Gur, R. E., Turetsky, B. I., Cowell, P. E., Finkelman, C.,Maany,V.,Grossman, R. I., et al. (2000). Temporolimbic volume reductions in schizophrenia. Arch. Gen. Psychiatry 57, 769-775.
28. Halim, N. D., Weickert, C. S., McClintock, B. W., Weinberger, D. R., and Lipska, B. K. (2004). Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 29, 1063-1069.
29. Haller, J. W., Banerjee, A., Christensen, G. E., Gado, M., Joshi, S., Miller, M. I., et al. (1997). Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomic atlas. Radiology 202, 504-510.
30. Haller, J. W., Christensen, G. E., Joshi, S. C., Newcomer, J. W., Miller, M. I., Csernansky, J. G., et al. (1996). Hippocampal MR imaging morphom-etry by means of general pattern matching. Radiology 199, 787-791.
31. Harrison, P. J. (2004). The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl.) 174, 151-162.
32. He, J., Kong, J., Tan, Q. R., and Li, X. M. (2009). Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models. Cell Adh. Migr. 3, 129-137.
33. Heckers, S., and Konradi, C. (2010). Hippocampal pathology in schizophrenia. Curr. Top. Behav. Neurosci. 4, 529-553.
34. Ho, B. C., Andreasen, N. C., Ziebell, S., Pierson, R., and Magnotta,V. (2011). Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry 68, 128-137.
35. Honea, R., Crow, T. J., Passingham, D., and MacKay, C. E. (2005). Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am. J. Psychiatry 162, 2233-2245.
36. Joyal, C. C., Laakso, M. P., Tiihonen, J., Syvalahti, E., Vilkman, H., Laakso, A., et al. (2003). The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neurolepticnaive patients. Biol. Psychiatry 54, 1302-1304.
37. Karow, A., Schnedler, D., and Naber, D. (2006). What would the patient choose? Subjective comparison of atypical and typical neuroleptics. Pharmacopsychiatry 39, 47-51.
38. Konradi, C., and Heckers, S. (2001). Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol. Psychiatry 50, 729-742.
39. Lahti, A. C., Holcomb, H. H., Weiler, M. A., Medoff, D. R., Frey, K. N., Hardin, M., et al. (2004). Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology 29, 171-178.
40. Lawrie, S. M., and Abukmeil, S. S. (1998). Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psychiatry 172, 110-120.
41. Lawrie, S. M., Whalley, H., Kestelman, J. N., Abukmeil, S. S., Byrne, M., Hodges, A., et al. (1999). Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet 353, 30-33.
42. Lieberman, J., Chakos, M., Wu, H., Alvir, J., Hoffman, E., Robinson, D., et al. (2001). Longitudinal study of brain morphology in first episode schizophrenia. Biol. Psychiatry 49, 487-499.
43. Lieberman, J. A. (1999). Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol. Psychiatry 46, 729-739.
44. Lieberman,J. A., Bymaster,F. P.,Meltzer, H. Y., Deutch, A. Y., Duncan, G. E., Marx, C. E., et al. (2008). Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol. Rev. 60, 358-403.
45. Lieberman, J. A., Tollefson, G. D., Charles, C., Zipursky, R., Sharma, T., Kahn, R. S., et al. (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 62, 361-370.
46. Loebel, A. D., Lieberman, J. A., Alvir, J. M., Mayerhoff, D. I., Geisler, S. H., and Szymanski, S. R. (1992). Duration of psychosis and outcome in first-episode schizophrenia. Am. J. Psychiatry 149, 1183-1188.
47. Mai, J. K., Assheuer, J., and Paxinos, G. (1997). Atlas of the Human Brain. San Diego: Academic Press.
48. Mamah, D., Barch,D. M., and Csernan-sky, J. G. (2009). "Neuromorpho-metric measures as endophenotypes of schizohprenia spectrum disorders," in The Handbook of Neuropsy-chiatric Biomarkers, Endophenotypes and Genes Volume II: Neuroanatom-ical and Neuroimaging Endophe-notypes and Biomarkers, ed. M. S. Ritsner (Dordrecht: Springer), 87-122.
49. Mamah, D., Wang, L., Csernansky, J. G., Rice, J. P., Smith, M., and Barch, D. M. (2010). Morphometryof the hippocampus and amygdala in bipolar disorder and schizophrenia. Bipolar Disord. 12, 341-343.
50. Marx, C. E., Van Doren, M. J., Duncan, G. E., Lieberman, J. A., and Morrow, A. L. (2003). Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology 28, 1-13.
51. Meltzer, H. Y., Park, S., and Kessler, R. (1999). Cognition, schizophrenia, and the atypical antipsychotic drugs. Proc. Natl. Acad. Sci. U.S.A. 96, 13591-13593.
52. Meltzer, H. Y., and Sumiyoshi, T. (2008). Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? Behav. Brain Res. 195, 98-102.
53. Miller, M., Banerjee, A., Christensen, G., Joshi, S., Khaneja, N., Grenan-der, U., et al. (1997a). Statistical methods in computational anatomy. Stat. Methods Med. Res. 6, 267-299.
54. Miller, D. D., Andreasen, N. C., O'Leary, D. S., Rezai, K., Watkins,G. L., Ponto, L. L.,et al. (1997b). Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography. Neuropsychopharmacology 17, 230-240.
55. Molina, V., Gispert, J. D., Reig, S., Sanz, J., Pascau, J., Santos, A., et al. (2003). Cerebral metabolism and risperi-done treatment in schizophrenia. Schizophr. Res. 60, 1-7.
56. Murphy, D. G., DeCarli, C., McIntosh, A. R., Daly, E., Mentis, M. J., Pietrini, P., et al. (1996). Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch. Gen. Psychiatry 53, 585-594.
57. Nelson, M. D., Saykin, A. J., Flashman, L. A., and Riordan, H. J. (1998). Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch. Gen. Psychiatry 55, 433-440.
58. Olney, J. W., and Farber, N. B. (1995). Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52, 998-1007.
59. Roberts,R. C., Gaither,L. A., Gao, X. M., Kashyap, S. M., and Tamminga, C. A. (1995). Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum. Synapse 20, 234-243.
60. Rollnik, J. D., Borsutzky, M., Huber, T. J., Mogk, H., Seifert, J., Emrich, H. M., et al. (2002). Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics. Neuropsychobiology 45, 74-80.
61. Schobel, S. A., Lewandowski, N. M., Corcoran, C. M., Moore, H., Brown, T., Malaspina, D., et al. (2009). Differential targeting of the CA1 sub-field of the hippocampal formation by schizophrenia and related psychotic disorders. Arch. Gen. Psychiatry 66, 938-946.
62. Selemon, L. D., and Goldman-Rakic, P. S. (1999). The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45, 17-25.
63. Shenton, M. E., Gerig, G., McCarley, R. W., Szekely, G., and Kikinis, R. (2002). Amygdala-hippocampal shape differences in schizophrenia: the application of 3D shape modelsto volumetric MR data.Psychiatry Res. 115, 15-35.
64. Steen, R. G., Mull, C., McClure, R., Hamer, R. M., and Lieberman, J. A. (2006). Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 188, 510-518.
65. Styner, M., Charles, H., Park, J., and Gerig, G. (2002). "Mutlisite validation of image analysis methods: assessing intra- and intersite variability," in Medical Imaging 2002: Image Processing, eds M. Sonka and J. Fitzpatrick (Bellingham: Walsh, International Society of Optical Engineering), 278-286.
66. Styner, M., Lieberman, J. A., Pantazis, D., and Gerig, G. (2004). Boundary and medial shape analysis of the hippocampus in schizophrenia. Med. Image Anal. 8, 197-203.
67. Sumich, A., Chitnis, X. A., Fannon, D. G., O'Ceallaigh, S., Doku, V. C., Fal-rowicz, A., et al. (2002). Temporal lobe abnormalities in first-episode psychosis. Am. J. Psychiatry 159, 1232-1235.
68. Szeszko, P. R., Strous, R. D., Goldman, R. S., Ashtari, M., Knuth, K. H., Lieberman, J. A., et al. (2002). Neu-ropsychological correlates of hip-pocampal volumes in patients experiencing a first episode of schizophrenia. Am. J. Psychiatry 159, 217-226.
69. Tamminga, C. A., Stan, A. D., and Wagner, A. D. (2010). The hippocampal formation in schizophrenia. Am. J. Psychiatry 167, 1178-1193.
70. Thompson, P. M., Woods, R. P., Mega, M. S., and Toga, A. W. (2000). Mathematical/computational challenges in creating deformable and probabilistic atlases of the human brain. Hum. Brain Mapp. 9, 81-92.
71. Velakoulis, D., Pantelis, C., McGorry, P. D., Dudgeon, P., Brewer, W., Cook, M., et al. (1999). Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch. Gen. Psychiatry 56, 133-141.
72. Velakoulis, D., Wood, S. J., McGorry, P. D., and Pantelis, C. (2000). Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. Aust. N. Z. J. Psychiatry 34(Suppl.), S113-S126.
73. Velakoulis, D., Wood, S. J., Wong, M. T., McGorry, P. D., Yung, A., Phillips, L., et al. (2006). Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia,first-episode psychosis, and ultra-high-risk individuals. Arch. Gen. Psychiatry 63, 139-149.
74. Vita, A., and de Peri, L. (2007). Hippocampal and amygdala volume reductions in first-episode schizophrenia. Br. J. Psychiatry 190, 271.
75. Wakade, C. G., Mahadik, S. P., Waller, J. L., and Chiu, F. C. (2002). Atypical neuroleptics stimulate neurogenesis in adult rat brain. J. Neurosci. Res. 69, 72-79.
76. Wang, L., Joshi, S. C., Miller, M. I., and Csernansky, J. G. (2001). Statistical analysis of hippocampal asymmetry in schizophrenia. Neuroimage 14, 531-545.
77. Wang, L., Mamah, D., Harms, M. P., Karnik, M., Price, J. L., Gado, M. H., et al. (2008). Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia. Biol. Psychiatry 64, 1060-1068.
78. Wang,L.,Miller,J.P.,Gado,M.H.,McKeel, D. W., Rothermich, M., Miller, M. I., et al. (2006). Abnormalities of hippocampal surface structure in very mild dementiaof the Alzheimer type. Neuroimage 30, 52-60.
79. White, L., Friedman, J. I., Bowie, C. R., Evers, M., Harvey, P. D., Parrella, M., et al. (2006). Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: retrospective comparison of first generation and second generation antipsychotics. Schizophr. Res. 88, 127-134.
80. Whitworth, A. B., Honeder, M., Kremser, C., Kemmler, G., Felber, S., Hausmann, A., et al. (1998). Hippocampal volume reduction in male schizophrenic patients. Schizophr. Res. 31, 73-81.
81. Whitworth, A. B., Kemmler, G., Honeder, M., Kremser, C., Felber, S., Hausmann, A., et al. (2005). Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients. Psychiatry Res. 140, 225-237.
82. Wood, S. J., Velakoulis, D., Smith, D. J., Bond, D., Stuart, G. W., McGorry, P. D., et al. (2001). A longitudinal studyof hippocampal volumeinfirst episode psychosis and chronic schizophrenia. Schizophr. Res. 52, 37-46.
83. Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W., David, A. S., Murray, R. M., and Bullmore, E. T. (2000). Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry 157, 16-25.